CADENCE PHARMACEUTICALS INC 4
4 · CADENCE PHARMACEUTICALS INC · Filed Jul 20, 2009
Insider Transaction Report
Form 4
Transactions
- Sale
Common stock
2009-07-20$11.00/sh−7,500$82,500→ 2,000 total - Exercise/Conversion
Common stock
2009-07-20$0.40/sh+7,500$3,000→ 9,500 total - Exercise/Conversion
Stock option (right to buy)
2009-07-20−7,500→ 72,500 totalExercise: $0.40From: 2005-02-16Exp: 2015-02-15→ common stock (7,500 underlying)
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2009.
- [F2]Not applicable to this transaction.